{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T11:47:50Z","timestamp":1784202470408,"version":"3.55.0"},"reference-count":26,"publisher":"BMJ","issue":"5","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Sex Transm Infect"],"accepted":{"date-parts":[[2013,1,5]]},"published-print":{"date-parts":[[2013,8]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>To investigate what factors influence the detection of<jats:italic>Chlamydia trachomatis<\/jats:italic>antibody following genital tract infection.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>One hundred and sixty-four women with a previous history of<jats:italic>C trachomatis<\/jats:italic>infection contributed to an earlier report on the performance of chlamydia antibody ELISA assays. We undertook further analysis to explore how chlamydia antibody assay sensitivity changes with time since infection.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Chlamydia antibody was detected in more women soon after the last detection of chlamydia at the lower genital tract than at later times. This holds true for all tests, but the Anilabsystems IgG EIA, Medac pELISA<jats:italic>plus<\/jats:italic>ELISA and the Savyon SeroCT-IgG ELISA were less sensitive than the pgp3 ELISA and the Anilabsystems microimmunofluorescence (MIF) assay at all time points except during current infection. Fall in seropositivity in women generally occurred in the early weeks and months following the last episode of chlamydia infection. There was no clear pattern of further reduction in seropositivity after 6\u2005months. Multiple previous episodes were associated with increased seropositivity in the pgp3 assay (two or more vs one, OR 19, p&lt;0.001) and other tests, but the effect was significantly smaller for the Anilabs, Medac and SeroCT MOMP peptide ELISAs, but not for the MIF assay.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Chlamydia antibody detection decreases with time since infection and this is most apparent in the first 6\u2005months. In women who have had more than one infection, antibody remained detectable longer for all tests, but this was more marked for the pgp3 ELISA and MIF assay.<\/jats:p><\/jats:sec>","DOI":"10.1136\/sextrans-2011-050386","type":"journal-article","created":{"date-parts":[[2013,2,22]],"date-time":"2013-02-22T02:43:27Z","timestamp":1361501007000},"page":"398-403","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":59,"title":["Effect of time since exposure to<i>Chlamydia trachomatis<\/i>on chlamydia antibody detection in women: a cross-sectional study"],"prefix":"10.1136","volume":"89","author":[{"given":"Patrick J","family":"Horner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian S","family":"Wills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosy","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A","family":"Muir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Winston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J","family":"Broadbent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myra O","family":"McClure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2013,2,21]]},"reference":[{"key":"2024051320594221000_89.5.398.1","unstructured":"Centers for Disease Control and Prevention. Sexually Transmitted Diseases Treatment Guidelines, 2010. http:\/\/www.cdc.gov\/std\/treatment\/2010\/STD-Treatment-2010-RR5912.pdf"},{"key":"2024051320594221000_89.5.398.2","unstructured":"National Chlamydia Screening Programme. Health Protection Agency. 2011. http:\/\/www.chlamydiascreening.nhs.uk\/ps\/index.asp"},{"key":"2024051320594221000_89.5.398.3","unstructured":"Ward H Fredlund H Gotz H . ECDC Guidance: Chlamydia control in Europe. 2009. http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/0906_GUI_Chlamydia _Control_in_Europe.pdf"},{"key":"2024051320594221000_89.5.398.4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39154.378079.BE"},{"key":"2024051320594221000_89.5.398.5","unstructured":"Genital Chlamydia trachomatis tests and diagnoses in young adults in England, 2011. Health Protection Report. 1 June 2012:6(22)."},{"key":"2024051320594221000_89.5.398.6","unstructured":"House of Commons Committee of Public Accounts. Young people's sexual health: the National Chlamydia Screening Programme. 2010. http:\/\/www.publications.parliament.uk\/pa\/cm200910\/cmselect\/cmpubacc\/283\/283.pdf"},{"key":"2024051320594221000_89.5.398.7","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2007.028662"},{"key":"2024051320594221000_89.5.398.8","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2008.030338"},{"key":"2024051320594221000_89.5.398.9","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e3182572475"},{"key":"2024051320594221000_89.5.398.10","doi-asserted-by":"crossref","unstructured":"Johnson AM Horner P . A new role for Chlamydia trachomatis serology? Sex Transm Infect 2008;84:79\u201380.","DOI":"10.1136\/sti.2007.028472"},{"key":"2024051320594221000_89.5.398.11","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00021-09"},{"key":"2024051320594221000_89.5.398.12","doi-asserted-by":"publisher","DOI":"10.1053\/beog.2002.0321"},{"key":"2024051320594221000_89.5.398.13","doi-asserted-by":"publisher","DOI":"10.1086\/315603"},{"key":"2024051320594221000_89.5.398.14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.322.7280.195"},{"key":"2024051320594221000_89.5.398.15","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2008.031138"},{"key":"2024051320594221000_89.5.398.16","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e3181a2a933"},{"key":"2024051320594221000_89.5.398.17","doi-asserted-by":"publisher","DOI":"10.1007\/s100960000397"},{"key":"2024051320594221000_89.5.398.18","doi-asserted-by":"publisher","DOI":"10.1258\/ijsa.2008.008489"},{"key":"2024051320594221000_89.5.398.19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0002-9378(80)91099-6","article-title":"Differences in some clinical and laboratory parameters in acute salpingitis related to culture and serologic findings","volume":"138","author":"Svensson","year":"1980","journal-title":"Am J Obstet Gynecol"},{"key":"2024051320594221000_89.5.398.20","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/00007435-200302000-00013","article-title":"The relationship of serovar to clinical manifestations of urogenital Chlamydia trachomatis infection","volume":"30","author":"Geisler","year":"2003","journal-title":"Sex Transm Dis"},{"key":"2024051320594221000_89.5.398.21","doi-asserted-by":"publisher","DOI":"10.1086\/315738"},{"key":"2024051320594221000_89.5.398.22","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/sti.2009.037036","article-title":"Serological reactivity and bacterial genotypes in Chlamydia trachomatis urogenital infections in Guadeloupe, French West Indies","volume":"86","author":"Weill","year":"2009","journal-title":"Sex Transm Infect"},{"key":"2024051320594221000_89.5.398.23","unstructured":"Horner P Wills G Pebody R . A comparative study of Chlamydia trachomatis PGP3 antibody elisa and two C. trachomatis specific momp peptide assays on sera from young people in the community. Chlamydial infections: Proceedings of the Twelfth International Symposium on human Chlamydial Infections; 2010; San Francisco, CA 94110: International Chlamydia Symposium, 2010:453\u20136."},{"key":"2024051320594221000_89.5.398.24","unstructured":"Oliver I Camm J . Access to Genitourinary medicine clinics. South West STI Task Force Quarterly Bulletin 2005. http:\/\/www.hpa.org.uk\/web\/HPAwebFile\/HPAweb_C\/1194947411400"},{"key":"2024051320594221000_89.5.398.25","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2007.027938"},{"key":"2024051320594221000_89.5.398.26","doi-asserted-by":"publisher","DOI":"10.1086\/497341"}],"container-title":["Sexually Transmitted Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/sextrans-2011-050386","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T04:49:29Z","timestamp":1715662169000},"score":1,"resource":{"primary":{"URL":"https:\/\/sti.bmj.com\/lookup\/doi\/10.1136\/sextrans-2011-050386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,21]]},"references-count":26,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,7,15]]},"published-print":{"date-parts":[[2013,8]]}},"alternative-id":["10.1136\/sextrans-2011-050386"],"URL":"https:\/\/doi.org\/10.1136\/sextrans-2011-050386","relation":{},"ISSN":["1368-4973","1472-3263"],"issn-type":[{"value":"1368-4973","type":"print"},{"value":"1472-3263","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,21]]}}}